Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection program

Haematologica

Volumn 89, Issue 7, 2004, Pages 852-856

  Pagano, Livio ^a   Fianchi, Luana ^a   Caramatti, Cecilia ^b   D'Antonio, Domenico ^c,d   Melillo, Lorella ^e   Caira, Morena ^a   Masini, Luciano ^f   Todeschini, Giuseppe ^g   Girmenia, Corrado ^h   Martino, Bruno ⁱ   Cinieri, Saverio ^j   Martino, Pietro ^h   Del Favero, Albano ^k  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

^d Ospedale di Pescara   (Italy)

^e Ospedale di S Giovanni Rotondo   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^j EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^k UNIVERSITY OF PERUGIA   (Italy)

more..

Author keywords

Cryptococcus spp.; Hematologic malignancies

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; BETA LACTAM ANTIBIOTIC; FLUCONAZOLE; FLUCYTOSINE; METHYLPREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS LAURENTII; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGUS CULTURE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER CIRRHOSIS; MALE; PIGEON; POLYMERASE CHAIN REACTION; RISK FACTOR; SKIN DISEASE; STEROID THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; FEMALE; FLUCONAZOLE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS;

EID: 3242810555     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991;13:1163-9.
2. Duperval R, Hermans PE, Brewer NS, Roberts GD. Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest 1977;72:13-9.
3. Collazos J. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 2003;17:-869-87.
4. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999;179:449-54.
5. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988;157:624-8.
6. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
7. Kontoyiannis DP, Peitsch WK, Reddy BT, Whimbey EE, Han XY, Bodey GP, et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001;32:E145-50.
8. Gendel BR, Ende M, Norman SL. Cryptococcosis. A review with special reference to apparent association with Hodgkin's disease. Am J Med 1950;9:343-55.
9. Kaplan MH, Rosen PP, Armstrong D. Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients. Cancer 1977;39:2265-74.
10. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:1098-107.
11. White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992;165:960-3.
12. Vigouroux S, Morin O, Milpied N, Mahe B, Rapp MJ, Harousseau JL. Cryptococcus neoformans infection in hematologic malignancies. Rev Med Interne 2000;21:955-60.
13. Melzer M, Colbridge M, Keenan F, Stainsby D, Ong EL. Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders. J Infect 1998;36:220-2.
14. Rhew DC, Gaultier CR, Daar ES, Zakowski PC, Said J. Infections in a patient with chronic adult T-cell leukaemia/lymphoma: case report and review. Clin Infect Dis 1995;36:1014-6.
15. Korfel A, Menssen HD, Schwartz S, Thiel E. Cryptococcosis in Hodgkin's disease: description of two cases and review of the literature. Ann Hematol 1998;283-6.
16. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
17. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Clin Infect Dis 2002;34:7-14.
18. Zinck SE, Leung AN, Fros M, Berry GJ, Muller NL. Pulmonary cryptococcosis: CT and pathologic findings. J Compt Ass Tom 2002;26:330-4.
19. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-6.
20. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003;36:789-94.
21. Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996;22 Suppl 2:S154-60.
22. de Lalla F, Pellizzer G, Vaglia A, Manfrin V, Franzetti M, Fabris P, et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively short period. Clin Infect Dis 1995;20:263-6.
23. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997;337:15-21.
24. Walsh T, Hiemennz JW, Seibel NI, Perfect JR, Horwith G, Lee L, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998;26:1383-96.
25. Valero G, Graybill JR. Successful treatment of cryptococcal meningitis with amphotericin B colloidal dispersion: report of four cases. Antimicrob Agents Chemother 1995;39:2588-90.
26. Vermes A, van Der Sijjs H, Guchelaar HJ. Flucytosine: correlation between toxicity and pharmacokinetic parameters. Chemotherapy 2000;46:86-94.
27. Adler-Moore J, Proffitt RT. Effect of tissue penetration on AmBisome efficacy. Curr Opin Investig Drugs 2003;4:179-85.